Walleye Capital’s Zimmer Biomet ZBH Stock Holding History

Walleye Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$492K	Sell	5,445 -2,657	-33%	-$244K	﹤0.01%	2684
2025 Q4	$729K	Buy	+8,102	New	+$768K	﹤0.01%	2676
2025 Q3	–	Sell	-2,822	Closed	-$280K	–	5236
2025 Q2	$257K	Sell	2,822 -5,176	-65%	-$500K	﹤0.01%	3178
2025 Q1	$905K	Sell	7,998 -22,493	-74%	-$2.41M	﹤0.01%	2050
2024 Q4	$3.22M	Sell	30,491 -68,768	-69%	-$7.38M	0.01%	1379
2024 Q3	$10.7M	Buy	99,259 +52,502	+112%	+$5.73M	0.02%	646
2024 Q2	$5.07M	Sell	46,757 -61,389	-57%	-$7.24M	0.01%	1277
2024 Q1	$14.3M	Buy	108,146 +94,684	+703%	+$11.8M	0.03%	597
2023 Q4	$1.64M	Sell	13,462 -124,628	-90%	-$13.9M	﹤0.01%	1949
2023 Q3	$15.5M	Buy	+138,090	New	+$17.5M	0.04%	358
2021 Q4	–	Sell	-51,091	Closed	-$7.26K	–	2355
2021 Q3	$7.26K	Buy	+51,091	New	+$7.52M	0.21%	50
2020 Q4	–	Sell	-2,353	Closed	-$311K	–	1133
2020 Q3	$311K	Buy	+2,353	New	+$307K	0.03%	500
2020 Q1	–	Sell	-720	Closed	-$105K	–	1775
2019 Q4	$105K	Buy	+720	New	+$99.4K	0.01%	1350

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's ZBH Position: Q1 2026 in Review

Walleye Capital reduced its Zimmer Biomet (ZBH) stake by 33% in Q1 2026, selling an estimated $244K and leaving 5,445 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Walleye Capital first reported a position in ZBH in Q4 2019 and has held it in 13 quarters since. The position peaked at $15.5M in Q3 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Walleye Capital held 5,445 shares of Zimmer Biomet worth $492K as of Q1 2026.
Walleye Capital sold 2,657 Zimmer Biomet shares in Q1 2026, an estimated $244K.
Zimmer Biomet made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2684 holding.
Walleye Capital first reported a position in Zimmer Biomet in Q4 2019 and has held it in 13 quarters since.
Walleye Capital's Zimmer Biomet position peaked at $15.5M in Q3 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.